Advantage Investment Management’s Novartis NVS Stock Holding History

Advantage Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$41K	Sell	474 -152	-24%	-$13.6K	0.03%	374
2019 Q2	$57K	Sell	626 -275	-31%	-$23.3K	0.04%	318
2019 Q1	$78K	Buy	901 +108	+14%	+$8.67K	0.06%	268
2018 Q4	$61K	Buy	793 +303	+62%	+$23.6K	0.05%	309
2018 Q3	$38K	Buy	490 +267	+120%	+$19.7K	0.02%	440
2018 Q2	$15K	Hold	223	–	–	0.01%	596
2018 Q1	$16K	Sell	223 -84	-27%	-$6.39K	0.01%	598
2017 Q4	$23K	Sell	307 -23	-7%	-$1.74K	0.01%	545
2017 Q3	$25K	Buy	330 +23	+7%	+$1.74K	0.01%	515
2017 Q2	$23K	Hold	307	–	–	0.01%	537
2017 Q1	$20K	Hold	307	–	–	0.01%	549
2016 Q4	$20K	Hold	307	–	–	0.01%	512
2016 Q3	$22K	Hold	307	–	–	0.01%	483
2016 Q2	$23K	Sell	307 -357	-54%	-$24.7K	0.01%	462
2016 Q1	$43K	Buy	664 +112	+20%	+$7.62K	0.02%	358
2015 Q4	$43K	Hold	552	–	–	0.02%	356
2015 Q3	$46K	Hold	552	–	–	0.03%	321
2015 Q2	$49K	Sell	552 -67	-11%	-$6.15K	0.02%	344
2015 Q1	$55K	Sell	619 -10	-2%	-$887	0.03%	311
2014 Q4	$52K	Buy	+629	New	+$52.1K	0.04%	305

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Advantage Investment Management's NVS Position: Q3 2019 in Review

Advantage Investment Management reduced its Novartis (NVS) stake by 24% in Q3 2019, selling an estimated $13.6K and leaving 474 shares worth $41K. The position accounts for 0.03% of the portfolio, ranked #374.

Advantage Investment Management first reported a position in NVS in Q4 2014 and has held it in 20 quarters since. The position peaked at $78K in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Advantage Investment Management held 474 shares of Novartis worth $41K as of Q3 2019.
Advantage Investment Management sold 152 Novartis shares in Q3 2019, an estimated $13.6K.
Novartis made up 0.03% of Advantage Investment Management's portfolio in Q3 2019, its #374 holding.
Advantage Investment Management first reported a position in Novartis in Q4 2014 and has held it in 20 quarters since.
Advantage Investment Management's Novartis position peaked at $78K in Q1 2019.
1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.